03.12.26 -- Supporting The Bioprocessing Workforce In The AI Era With Sanofi

See how AI is transforming visual inspection and gain a deep understanding of defect detection, real-time performance, and integration challenges.

Global research teams were generating critical data in disconnected systems, hindering collaboration. Explore how unified workflows and a shared data backbone strengthen efficiency.

JHS partnered with a global pharma company to optimize biologic production, increasing output by 50% and reducing batch release times by up to 30%.

Traditional biomanufacturing relies too heavily on trial and error. By integrating AI and mechanistic models into early design, developers can overcome productivity limits and accelerate timelines.

Digital validation management cuts lifecycle times by up to 80%. Learn how unified solutions streamline processes, enhance audit readiness, and deliver measurable ROI for faster, smarter operations.

Discover how AI, digital twins, and automation are transforming biomanufacturing by cutting costs, improving quality, and accelerating timelines for smarter, more efficient production.

Examine a structured framework for qualifying single-use component changes, with risk-based strategies, supplier insights, and practical tools to support resilient and compliant biomanufacturing.

Gain insight into how Industry 4.0 integration transforms pharma manufacturing through connected systems, data-driven insights, and predictive, compliant operations.

Accelerate drug development with AI. Enhance process intelligence and achieve gold-standard data sets with the right digital tools and improved maturity.

In the evolving world of biopharmaceutical manufacturing, explore how single-use filtration remains a vital yet overlooked process essential to ensuring product purity and patient safety.

A robust cleanroom monitoring program is your best defense against contamination. Align your strategy with Annex 1 to detect risks early, protect your product, and ensure patient safety.

The global market for injectable drugs will reach $69.13 billion by 2028. Review the vital role of laminar airflow technology in meeting sterile integrity standards and minimizing contamination risks.

Learn more about the evolution of one company's solutions for biopharmaceutical manufacturing and accelerating market entrance using single-use technology.

For pharmaceutical and chemical manufacturers, balancing budgets with operational needs is crucial. Find out how sourcing used equipment offers significant cost advantages over new.

GMP compliance requires monitoring microbial contamination levels in cleanrooms and clean spaces. It is important to know the role active air samplers play in this process and parameters for evaluating them.